CLDX - Celldex Therapeutics, Inc.
29.43
0.070 0.238%
Share volume: 672,383
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$29.36
0.07
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-06-2024 | 08-08-2024 | 11-06-2024 | 02-27-2025 | 05-08-2025 | 08-07-2025 | 11-10-2025 | 02-25-2026 | |
| Total revenue | 156.000 K | 2.498 M | 3.191 M | 1.175 M | 695.000 K | 730.000 K | 0.000 | 120.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 156.000 K | 2.498 M | 3.191 M | 1.175 M | 695.000 K | 730.000 K | 0.000 | 120.000 K | |
| 1,501.28% | 27.74% | -63.18% | -40.85% | 5.04% | -100.00% | inf% | |||
| Operating expenses | 40.764 M | 48.815 M | 55.317 M | 57.202 M | 63.434 M | 64.587 M | 73.617 M | 87.274 M | |
| Selling general and admin | 9.103 M | 9.128 M | 10.054 M | 10.263 M | 10.820 M | 10.391 M | 10.686 M | 11.941 M | |
| Research and development | 31.661 M | 39.687 M | 45.263 M | 46.939 M | 52.614 M | 54.196 M | 62.931 M | 75.333 M | |
| Total expenses | 40.764 M | 48.815 M | 55.317 M | 57.202 M | 63.434 M | 64.587 M | 73.617 M | 87.274 M | |
| 19.75% | 13.32% | 3.41% | 10.89% | 1.82% | 13.98% | 18.55% | |||
| Operating income | -40.608 M | -46.317 M | -52.126 M | -56.027 M | -62.739 M | -63.857 M | -73.617 M | -87.154 M | |
| Ebit | -40.608 M | -46.317 M | -52.126 M | -56.027 M | -62.739 M | -63.857 M | -73.617 M | -87.154 M | |
| Pretax income | 0.000 | 0.000 | 0.000 | -157.863 M | -53.796 M | -56.600 M | -67.044 M | -81.317 M | |
| nan% | nan% | inf% | -65.92% | 5.21% | 18.45% | 21.29% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -32.808 M | -35.842 M | -42.121 M | -47.092 M | -53.796 M | -56.600 M | -67.044 M | -81.317 M | |
| -9.25% | -17.52% | -11.80% | -14.24% | -5.21% | -18.45% | -21.29% |